(Q35523534)

8 August 2017

1 reference

19 September 2019

Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness (English)

1 reference

biomedical investigative technique

8 August 2017

1 reference

19 September 2019

1 reference

19 September 2019

Elizabeth V Hillyer

5

0 references

David Price

object named as

David Price

series ordinal

1

0 references

Nicolas Roche

object named as

Nicolas Roche

series ordinal

4

0 references

Jean Bousquet

series ordinal

6

object named as

Jean Bousquet

1 reference

8 August 2017

2

Alison Chisholm

1 reference

8 August 2017

Thys van der Molen

3

1 reference

8 August 2017

1 December 2011

2 references

Current Allergy and Asthma Reports

8 August 2017

19 September 2019

2 references

8 August 2017

19 September 2019

11

1 reference

8 August 2017

6

1 reference

8 August 2017

526-538

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

8 August 2017

start time

17 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s11882-011-0222-7

0 references

cites work

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Pragmatic trials--guides to better patient care?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

A call for action: Comparative effectiveness research in asthma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Impact of comorbidities on asthma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Against pragmatism: on efficacy, effectiveness and the real world

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Efficacy of esomeprazole for treatment of poorly controlled asthma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Improving the reporting of pragmatic trials: an extension of the CONSORT statement

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Achieving asthma control in practice: understanding the reasons for poor control

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Breaking new ground: challenging existing asthma guidelines

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

CONSORT statement: extension to cluster randomised trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Database studies in asthma pharmacoeconomics: uses, limitations and quality markers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Representation of elderly persons and women in published randomized trials of acute coronary syndromes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

A comparison of observational studies and randomized, controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Beclomethasone for asthma in children: effects on linear growth

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Factors that limit the quality, number and progress of randomised controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Explanatory and pragmatic attitudes in therapeutical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Spirometric criteria for asthma: adding further evidence to the debate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Does smoking affect the outcome of patient education and self-management in asthmatics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Limitations of "pragmatic" trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Validity of the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Treatment patterns in the months prior to and after asthma-related emergency department visit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Are overweight asthmatics more difficult to control?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208109

Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper

26 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

The Brussels Declaration: the need for change in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0222-7

Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults

21 January 2018

1 reference

12 December 2020

How do observational studies expand the evidence base for therapy?

1 reference

12 December 2020

Clinical trials and tribulations: the MASCOT study

1 reference

12 December 2020

Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI

1 reference

12 December 2020

Cigarette smoking and asthma symptom severity among adult asthmatics

1 reference

12 December 2020

How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?

1 reference

12 December 2020

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

1 reference

12 December 2020

High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study

1 reference

12 December 2020

Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study

1 reference

12 December 2020

Higher BMI is associated with worse asthma control and quality of life but not asthma severity

1 reference

12 December 2020

Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability

1 reference

12 December 2020

The true cost of pharmacological disease prevention

1 reference

12 December 2020

How representative are clinical study patients with allergic rhinitis in primary care?

1 reference

12 December 2020

Cigarette smoking stimulates cysteinyl leukotriene production in man

1 reference

12 December 2020

10.1007/S11882-011-0222-7

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

21927929